OxCODE Funding Scheme
Mission & Overview
The mission of the Oxford Centre for Early Cancer Detection (OxCODE) Funding Scheme is to advance innovative Oxford-based research that can be applied to cancer precision prevention and/or cancer earlier detection. Precision prevention is part of an expanded remit for OxCODE and is defined by translational research that will build and use greater biological and mechanistic understanding of cancer aetiology, genesis and risk, in order to lead to biologically informed preventative interventions.
OxCODE aims to pump-prime this research by providing short-term awards that will enable the development of proof-of-concept projects, technologies, assays, and platforms to a stage at which more long-term external funding can be sought. We would also welcome proposals that build our capabilities in data analytics and integration. Collaborative projects that cross discipline boundaries are encouraged. Fundamental science and clinical research proposals are welcome. Priority will be given to projects with a clearly articulated translational trajectory towards the ultimate longer-term goal of improving clinical outcomes by lowering cancer risk or incidence, or through earlier detection.
Maximum amount per award: £25,000
Award length: up to 12 months; funds must be fully spent by 30th June 2025
Eligibility: the lead applicant must be
- an OxCODE member
- employed by either the University of Oxford or OUH NHS Trust for the duration of the award
- an independent PI or post-doctoral researcher with the support of their PI
The 2024-2025 round of the OxCODE funding scheme is currently open and will close on 22nd Februrary 2024.
Please contact firstname.lastname@example.org for the scheme guidance and application form.